EMA Begins Setting Up New Bodies To Tackle Drug Shortages
Workshop To Be Held To Explain Agency's Expanded Role
Executive Summary
A new EU regulation has come into effect, giving the European Medicines Agency wider powers to monitor, prevent and manage shortages of medicines and medical devices in public health emergencies. A number of steering groups and other bodies and networks are being set up to put the new systems into action.
You may also be interested in...
EMA: Five-Year Regulatory Network Strategy Still ‘Valid And Relevant’ At Midway Point
A report by the European Medicines Agency outlines the progress that has been made so far in delivering on the key pillars of its five-year network strategy, proposed in 2020, and lists areas where work is ongoing.
New EU Body To Take The Strain As Talks On Pharma Overhaul Near
A new EU subcommittee is to be set up to advise on matters relating to pharmaceuticals, the European Medicines Agency and public health.
‘Main Issue’ Facing Generics Security Of Supply Is Price, Politico Panel Hears
Panelists discussed the issues jeopardizing generics security of supply, the potential impact of pricing changes and international best practice at a recent Politico event.